Increased levels of NfL in cerebrospinal fluid and blood are found routinely in association with clinical progression of primary neurodegenerative diseases including Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease and Charcot–Marie–Tooth disease (reviewed in [30]). This evidence concerns the gene NEFL and Alzheimer disease.